Non-steroidal anti-inflammatory drugs sensitize CD44-overexpressing cancer cells to Hsp90 inhibitor through autophagy activation.

In conclusion, combining NSAID with Hsp90 inhibitor may offer one of the most promising strategies for eradication of CD44-overexpressing CSCs. PMID: 30982499 [PubMed - as supplied by publisher]
Source: Oncology Research - Category: Cancer & Oncology Tags: Oncol Res Source Type: research